Grants

Highly competitive national selection highlights the strong scientific and clinical potential of EVis’s technology Zurich, Switzerland. EVis Bioscience AG, an ETH Zurich spin-off developing next-generation RNA delivery systems, has been selected by Innosuisse, the Swiss Innovation Agency, to receive CHF 311,000 in non-dilutive funding. This grant, awarded through a highly competitive evaluation process, will support…

➡️Learn more about the Innovation Cheque

We are delighted to share our successful second stage! 🎉 Thank you to Venture Kick for believing in us again and for their invaluable support on this exciting journey. ➡️ Learn more about the Stage II

🚀 EVis Bioscience has been granted by Venture Kick (stage I).The EVis team is thankful and honored to receive this fund and will do the best job for the next phase. ➡️ Learn more about Venture Kick